135 related articles for article (PubMed ID: 36961616)
1. Clinical value of minimum apparent diffusion coefficient for prediction of clinically significant prostate cancer in the transition zone.
Ono A; Hashimoto T; Shishido T; Hirasawa Y; Satake N; Namiki K; Saito K; Ohno Y
Int J Clin Oncol; 2023 May; 28(5):716-723. PubMed ID: 36961616
[TBL] [Abstract][Full Text] [Related]
2. Prospective Inclusion of Apparent Diffusion Coefficients in Multiparametric Prostate MRI Structured Reports: Discrimination of Clinically Insignificant and Significant Cancers.
Costa DN; Xi Y; Aziz M; Passoni N; Shakir N; Goldberg K; Francis F; Roehrborn CG; Leon AD; Pedrosa I
AJR Am J Roentgenol; 2019 Jan; 212(1):109-116. PubMed ID: 30383404
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Analysis of Diffusion Weighted Imaging May Improve Risk Stratification of Prostatic Transition Zone Lesions.
Engel H; Oerther B; Reisert M; Kellner E; Sigle A; Gratzke C; Bronsert P; Krauss T; Bamberg F; Benndorf M
In Vivo; 2022; 36(5):2323-2331. PubMed ID: 36099133
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted magnetic resonance imaging in the prostate transition zone: histopathological validation using magnetic resonance-guided biopsy specimens.
Hoeks CM; Vos EK; Bomers JG; Barentsz JO; Hulsbergen-van de Kaa CA; Scheenen TW
Invest Radiol; 2013 Oct; 48(10):693-701. PubMed ID: 23614975
[TBL] [Abstract][Full Text] [Related]
5. Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center.
Hermie I; Van Besien J; De Visschere P; Lumen N; Decaestecker K
Eur J Radiol; 2019 May; 114():92-98. PubMed ID: 31005183
[TBL] [Abstract][Full Text] [Related]
6. Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer.
Tavakoli AA; Hielscher T; Badura P; Görtz M; Kuder TA; Gnirs R; Schwab C; Hohenfellner M; Schlemmer HP; Bonekamp D
Radiology; 2023 Jan; 306(1):186-199. PubMed ID: 35972360
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
8. Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?
Felker ER; Raman SS; Margolis DJ; Lu DSK; Shaheen N; Natarajan S; Sharma D; Huang J; Dorey F; Marks LS
AJR Am J Roentgenol; 2017 Dec; 209(6):1272-1277. PubMed ID: 28858541
[TBL] [Abstract][Full Text] [Related]
9. Central zone lesions on magnetic resonance imaging: Should we be concerned?
Tan WP; Mazzone A; Shors S; Antoine N; Ekbal S; Khare N; McKiel C; Pessis D; Deane L
Urol Oncol; 2017 Jan; 35(1):31.e7-31.e12. PubMed ID: 27692837
[TBL] [Abstract][Full Text] [Related]
10. Dynamic Contrast Enhanced Magnetic Resonance Imaging Improves Classification of Prostate Lesions: A Study of Pathological Outcomes on Targeted Prostate Biopsy.
Druskin SC; Ward R; Purysko AS; Young A; Tosoian JJ; Ghabili K; Andreas D; Klein E; Ross AE; Macura KJ
J Urol; 2017 Dec; 198(6):1301-1308. PubMed ID: 28709889
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric MR can identify high grade prostatic intraepithelial neoplasia (HGPIN) lesions and predict future detection of prostate cancer in men with a negative initial prostate biopsy.
Dwivedi DK; Kumar R; Bora GS; Sharma S; Thulkar S; Gupta SD; Jagannathan NR
Magn Reson Imaging; 2016 Oct; 34(8):1081-6. PubMed ID: 27211254
[TBL] [Abstract][Full Text] [Related]
12. Utility of quantitative apparent diffusion coefficient measurements and normalized apparent diffusion coefficient ratios in the diagnosis of clinically significant peripheral zone prostate cancer.
Nguyen TB; Ushinsky A; Yang A; Nguyentat M; Fardin S; Uchio E; Lall C; Lee T; Houshyar R
Br J Radiol; 2018 Jul; 91(1088):20180091. PubMed ID: 29869921
[TBL] [Abstract][Full Text] [Related]
13. Objective value on Apparent diffusion coefficient (ADC) map to categorize the intensity of diffusion-weighted imaging (DWI) restriction for prostate cancer detection on multiparametric prostate MRI.
Mussi TC; Martins T; Tachibana A; Mousessian PN; Baroni RH
Int Braz J Urol; 2018; 44(5):882-891. PubMed ID: 30044597
[TBL] [Abstract][Full Text] [Related]
14. T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment.
Al-Bourini O; Seif Amir Hosseini A; Giganti F; Balz J; Heitz LG; Voit D; Lotz J; Trojan L; Frahm J; Uhlig A; Uhlig J
Invest Radiol; 2023 Jun; 58(6):380-387. PubMed ID: 36729865
[TBL] [Abstract][Full Text] [Related]
15. Detection rate of clinically significant prostate cancer in magnetic resonance imaging and ultrasonography-fusion transperineal targeted biopsy for lesions with a prostate imaging reporting and data system version 2 score of 3-5.
Hakozaki Y; Matsushima H; Murata T; Masuda T; Hirai Y; Oda M; Kawauchi N; Yokoyama M; Kume H
Int J Urol; 2019 Feb; 26(2):217-222. PubMed ID: 30461076
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate.
Sato C; Naganawa S; Nakamura T; Kumada H; Miura S; Takizawa O; Ishigaki T
J Magn Reson Imaging; 2005 Mar; 21(3):258-62. PubMed ID: 15723379
[TBL] [Abstract][Full Text] [Related]
17. Transition zone prostate cancer: incremental value of diffusion-weighted endorectal MR imaging in tumor detection and assessment of aggressiveness.
Jung SI; Donati OF; Vargas HA; Goldman D; Hricak H; Akin O
Radiology; 2013 Nov; 269(2):493-503. PubMed ID: 23878284
[TBL] [Abstract][Full Text] [Related]
18. Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI.
Bajgiran AM; Mirak SA; Sung K; Sisk AE; Reiter RE; Raman SS
AJR Am J Roentgenol; 2019 Sep; 213(3):W134-W142. PubMed ID: 31216201
[No Abstract] [Full Text] [Related]
19. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
20. The value of diffusion-weighted MRI for prostate cancer detection and localization.
Yağci AB; Ozari N; Aybek Z; Düzcan E
Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]